We interviewed Tapley Holland and Adam Breiner ND about TruDOSE™ platelet-rich plasma therapy for autism, Lyme, PANS/PANDAS and autoimmune conditions. You can watch the replay below. Please note that you will be asked to provide your email address at the 30-minute mark to continue viewing the replay.
What Is Platelet-Rich Plasma Therapy?
Platelet-Rich Plasma (PRP) therapy is probably best known for its ability to restore hair and other cosmetic-surgery procedures because platelets in plasma from one’s own blood can boost tissue regeneration. It is also used in sports medicine to help athletes heal from sports injuries. Tiger Woods is probably the most well known example of a major athlete who used PRP therapy to recover from injuries.
Why Is TruDOSE™ Platelet-Rich Plasma Therapy Different?
The problem with traditional PRP therapy is the dose and concentration of platelets within the plasma. Some people need more, and some people need less. TruDOSE™ solves this dosing-inaccuracy problem with the use of its patented intelligent software testing platform that provides the ability to infuse dose-specific platelets back into the body.
In This Webinar
In this webinar, Tapley and Dr. Breiner helped us to answer the following questions:
- What is Platelet-Rich Plasma (PRP) therapy?
- How is TruDOSE™ PRP therapy different from traditional PRP therapy?
- Why does this difference matter?
- How is TruDOSE™ different from IVIG (IntraVenous ImmunoGlobulin) therapy and plasmapheresis?
- How can TruDOSE™ help those with Lyme disease, autism, PANS/PANDAS and autoimmune conditions?
Key Discussions
Platelet-Rich Plasma Therapy (PRP) Explanation
Platelet-rich plasma therapy uses a person’s own platelets to stimulate healing. This involves drawing blood, processing it to concentrate the platelets, and then injecting it back into a target area. The technology developed by Tapley Holland aims to personalize and optimize the dosing for better outcomes.
TruDOSE™ Technology
TruDOSE™ technology is a patented software platform created to address dosing inaccuracies in regenerative medicine. It personalizes treatment by determining the specific dose of platelets needed for an individual’s therapeutic benefit.
Emotional and Metabolic Health
The emotional and metabolic states of individuals can significantly impact their overall health and healing process. The therapy can help patients with complex conditions, including emotional regulation and metabolic dysfunction through a recalibration of the body’s systems.
Holistic Approach to Treatment
Both Tapley and Dr. Breiner emphasized a holistic approach that includes lifestyle, dietary changes, detoxification, and personalized medical therapy. A combination of TruDOSE™ and other natural and therapeutic approaches can contribute to significant health improvements.
Application and Outcomes
The application of TruDOSE™ is extensive, showing positive outcomes in various health conditions such as autism, traumatic brain injury, and other chronic health issues. However, it is essential to monitor patients closely and adjust treatment as needed to address individual health.
TruDOSE™ Study
The We The People Health & Wellness Center in Venice, FL is offering free TruDOSE™ to children with autism in a study that is pending IRB approval. Children must qualify for the study, and the treatments would be free of charge if they qualify. For those that are interested, go to https://www.wtphealthcare.com/autismstudy
Timestamped Overview
00:00 Self-taught stem cell expert
06:36 Platelets: Key to healing son?
10:58 “Platelet Rich Plasma (PRP) overview”
21:17 Platelets: Body’s first responders
27:41 Platelets’ role in healing process
32:37 Metabolic dysfunction therapy strategies
36:15 Parasite load reduced
46:21 Personalized health analysis tools
52:08 Targeted healing with frequencies
57:01 Rethinking thyroid treatment mechanisms
01:00:09 Platelet treatment for emotional healing
01:06:35 Identifying infectious load in treatments
01:14:05 Advancing autism research
01:19:26 Benefits of treatment
01:23:33 Limit anti-inflammatory use before treatment
01:27:14 Glaucoma relief after 40 years
01:33:20 Evaluating healthcare approaches
01:39:14 Expected reaction to treatment
01:44:13 Emotional impact of medical treatments
01:48:45 Rapid in-office platelet therapy
01:56:29 Emotional response
About Tapley Holland
Tapley Holland is the creator of the TruDOSE™ Technology, a patented intelligent software testing platform that solved the longstanding dosing inaccuracy problem within the field of regenerative medicine.
This technology led to uncovering the healing benefits of infusing dose-specific platelets back into the bloodstream, otherwise known as TruDOSE™ IV platelet therapy.
Since 2018, the TruDOSE™ technology and IV therapy have treated, and reversed, thousands of patients with unsolvable symptoms and disease conditions.
You can find out more about him and TruDOSE™ at https://trudose.com/
About Adam Breiner ND
Dr. Adam Breiner, ND is a naturopathic physician. Dr. Breiner is the first physician in the State of Connecticut to offer hyperbaric oxygen for the treatment of Lyme, stroke, autism, ADD/ADHD, TBI, and other neurological conditions.
He has helped patients with a wide variety of neurological conditions utilizing cutting-edge techniques and technologies including HyperBaric Oxygen Therapy (HBOT), EEG neurofeedback, and Frequency Specific Microcurrent (FSM), biobagnetism, and TruDose™ therapy for over twenty years. He has had the privilege of working with many of the pioneers in these fields, including Dr. Richard Neubauer, the father of hyperbaric medicine for neurological conditions, and Dr. Margaret Ayers, inventor of the world’s first Real-Time EEG and pioneer in the field of neurofeedback. In addition to neurological conditions, patients from NYC, Connecticut, and New England seek out Dr. Adam Breiner for his natural and cutting-edge approaches in the treatment of Lyme disease and other complex conditions. You can find out more about him and his practice at his website: https://wholebodymed.com/
Disclaimer
This webinar is not a substitute for medical advice, treatment, diagnosis, or consultation with a medical professional. It is intended for general informational purposes only and should not be relied on to make determinations related to treatment of a medical condition. Documenting Hope has not verified and does not guaranty the accuracy of the information provided in this webinar.
Still Looking for Answers?
Visit the Documenting Hope Practitioner Directory to find a practitioner near you.
Join us inside our online membership community for parents, Healing Together, where you’ll find even more healing resources, expert guidance, and a community to support you every step of your child’s healing journey.
Sources & References
Çelik, T., et al. Treatment of Lyme neuroborreliosis with plasmapheresis. J Clin Apher. 2016 Oct;31(5):476-8.
Eremija, J., et al. Intravenous immunoglobulin treatment improves multiple neuropsychiatric outcomes in patients with pediatric acute-onset neuropsychiatric syndrome. Front Pediatr. 2023 Oct 16:11:1229150.
Hajjari, P., et al. Paediatric Acute-onset Neuropsychiatric Syndrome (PANS) and intravenous immunoglobulin (IVIG): comprehensive open-label trial in ten children. BMC Psychiatry. 2022 Aug 6;22(1):535.
Jain, N.K., et al. Platelet-rich plasma: a healing virtuoso. Blood Res. 2016 Mar;51(1):3-5.
Kumar, K., et al. Comparison of Platelet-Rich Plasma and Corticosteroid Injections for Chronic Plantar Fasciitis: A Randomized Controlled Trial. Cureus. 2024 May 4;16(5):e59656.
Melamed, I.R., et al. A pilot study of high-dose intravenous immunoglobulin 5% for autism: Impact on autism spectrum and markers of neuroinflammation. Autism Res. 2018 Mar;11(3):421-433.
Melamed, I., et al. Evaluation of Intravenous Immunoglobulin in Pediatric Acute-Onset Neuropsychiatric Syndrome. J Child Adolesc Psychopharmacol. 2021 Mar;31(2):118-128.
Melamed, I., et al. IVIG response in pediatric acute-onset neuropsychiatric syndrome correlates with reduction in pro-inflammatory monocytes and neuropsychiatric measures.
Front Immunol. 2024 Oct 3:15:1383973.
Rossignol, D.A., et al. A Systematic Review and Meta-Analysis of Immunoglobulin G Abnormalities and the Therapeutic Use of Intravenous Immunoglobulins (IVIG) in Autism Spectrum Disorder. J Pers Med. 2021 May 30;11(6):488.
Resources
Articles
Lowery, Heather. The Next Big Thing in PRP Therapy. New York Center for Innovative Medicine.
Tiger Admits to Platelet-Rich Plasma Therapy, What's That? ABC News, 7 Apr 2010.
Wernau, Julie. Health Insurers Deny 850 Million Claims a Year. The Few Who Appeal Often Win. Wall Street Journal, 12 Feb 2025.
